Advertisement

Journal of Inherited Metabolic Disease

, Volume 41, Issue 6, pp 917–927 | Cite as

Role of continuous glucose monitoring in the management of glycogen storage disorders

  • Mrudu Herbert
  • Surekha Pendyal
  • Mugdha Rairikar
  • Carine Halaby
  • Robert W. Benjamin
  • Priya S. KishnaniEmail author
Glycogen Storage Disease
  • 316 Downloads

Abstract

Management of liver glycogen storage diseases (GSDs) primarily involves maintaining normoglycemia through dietary modifications and regular glucose monitoring. Self-monitoring of blood glucose is typically done 3–6 times per day, and may not sufficiently capture periods of asymptomatic hypoglycemia, particularly during sleep. Continuous glucose monitoring systems (CGMS) provide 24-h continuous glucose data and have been used effectively in diabetes mellitus to monitor metabolic control and optimize treatment. This is a relatively new approach in GSDs with only a handful of studies exploring this modality. In this study we used Dexcom CGMS to study the glycemic profile of 14 pediatric and six adult patients with GSD I, III, and IX. A total of 176 days of CGMS data were available. The CGMS was found to be a reliable tool in monitoring glucose levels and trends at all times of the day with good concordance with finger-stick glucose values. This study revealed that in addition to overnight hypoglycemia, CGMS can uncover previously undetected, subclinical, low glucose levels during daytime hours. Additionally, the CGMS detected daytime and overnight hyperglycemia, an often overlooked concern in liver GSDs. The CGMS with concurrent dietary adjustments made by a metabolic dietitian improved metabolic parameters and stabilized blood glucose levels. The CGMS was found to be a safe, effective, and reliable method for optimizing treatment in patients with GSD I, III, and IX.

Notes

Funding

No external funding sources were used for this study.

Compliance with ethical standards

Conflict of interest

M. Herbert, S. Pendyal, M. Rairikar, C. Halaby, R. W. Benjamin, and P. S. Kishnani declare that they have no conflict of interest.

Animal rights

This article does not contain any studies with human or animal subjects performed by the any of the authors.

References

  1. Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW, Replace-Bg Study Group (2017) REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care 40:538–545CrossRefGoogle Scholar
  2. Allen NA, Fain JA, Braun B, Chipkin SR (2008) Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract 80:371–379CrossRefGoogle Scholar
  3. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J (2011) Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 34:795–800CrossRefGoogle Scholar
  4. Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, Diamond Study Group (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317:371–378CrossRefGoogle Scholar
  5. Charleer S, Mathieu C, Nobels F, De Block C, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T’Sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P (2018) Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab 103:1224–1232CrossRefGoogle Scholar
  6. Choudhary P, Geddes J, Freeman JV, Emery CJ, Heller SR, Frier BM (2010) Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med 27:666–672CrossRefGoogle Scholar
  7. Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ (2014) A comparative effectiveness analysis of three continuous glucose monitors: the navigator, G4 platinum, and enlite. J Diabetes Sci Technol 8:699–708CrossRefGoogle Scholar
  8. FDA (2016) Dexcom G5 Mobile Continuous Glucose Monitoring System. Retrieved from https://www.fda.gov/downloads/AdvisoryCommittees/.../UCM511810.pdf
  9. Fonda SJ, Graham C, Munakata J, Powers JM, Price D, Vigersky RA (2016) The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes. J Diabetes Sci Technol 10:898–904CrossRefGoogle Scholar
  10. Gold AE, MacLeod KM, Frier BM (1994) Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697–703CrossRefGoogle Scholar
  11. Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M (2001) Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 24:863–869CrossRefGoogle Scholar
  12. Huang ES, O’Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T (2010) The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 33:1269–1274CrossRefGoogle Scholar
  13. Jellinger PS (2007) Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 8(Suppl 7):S30–S42CrossRefGoogle Scholar
  14. Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014) Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68:101–105CrossRefGoogle Scholar
  15. Kishnani PS, Chen YT (2016) Defects in metabolism of carbohydrates. In: Stanton B, Kliegman R, St. Geme J, Schor N, Behrman R (eds) Nelson textbook of pediatrics. Elsevier, PhiladelphiaGoogle Scholar
  16. Klonoff DC, Ahn D, Drincic A (2017) Continuous glucose monitoring: a review of the technology and clinical use. Diabetes Res Clin Pract 133:178–192CrossRefGoogle Scholar
  17. Kovatchev BP (2015) Hypoglycemia reduction and accuracy of continuous glucose monitoring. Diabetes Technol Ther 17:530–533CrossRefGoogle Scholar
  18. Laffel L (2016) Improved accuracy of continuous glucose monitoring systems in pediatric patients with diabetes mellitus: results from two studies. Diabetes Technol Ther 18(Suppl 2):S223–S233CrossRefGoogle Scholar
  19. Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Olafsdottir AF, Frid A, Wedel H, Ahlen E, Nystrom T, Hellman J (2017) Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317:379–387CrossRefGoogle Scholar
  20. Mangrola D, Cox C, Furman AS, Krishnan S, Karakas SE (2017) Self-blood glucose monitoring underestimates hyperglycemia and hypoglycemia as compared to continuous glucose monitoring in type 1 and type 2 diabetes. Endocr Pract. https://doi.org/10.4158/EP-2017-0032Google Scholar
  21. Maran A, Crepaldi C, Avogaro A, Catuogno S, Burlina A, Poscia A, Tiengo A (2004) Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev 20(Suppl 2):S50–S55CrossRefGoogle Scholar
  22. Martin-Timon I, Del Canizo-Gomez FJ (2015) Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes 6:912–926CrossRefGoogle Scholar
  23. Nakamura K, Balo A (2015) The accuracy and efficacy of the Dexcom G4 platinum continuous glucose monitoring system. J Diabetes Sci Technol 9:1021–1026CrossRefGoogle Scholar
  24. Oki Y, Okubo M, Tanaka S, Nakanishi K, Kobayashi T, Murase T (2000) Diabetes mellitus secondary to glycogen storage disease type III. Diabet Med 17:810–812CrossRefGoogle Scholar
  25. Polonsky WH, Hessler D (2013) What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther 15:295–301CrossRefGoogle Scholar
  26. Shivers JP, Mackowiak L, Anhalt H, Zisser H (2013) “Turn it off!”: diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol 7:789–794CrossRefGoogle Scholar
  27. Spaic T, Driscoll M, Raghinaru D, Buckingham BA, Wilson DM, Clinton P, Chase HP, Maahs DM, Forlenza GP, Jost E, Hramiak I, Paul T, Bequette BW, Cameron F, Beck RW, Kollman C, Lum JW, Ly TT, Group In-Home Closed-Loop Study (2017) Predictive hyperglycemia and hypoglycemia minimization: in-home evaluation of safety, feasibility, and efficacy in overnight glucose control in type 1 diabetes. Diabetes Care 40:359–366CrossRefGoogle Scholar
  28. Spengos K, Michelakakis H, Vontzalidis A, Zouvelou V, Manta P (2009) Diabetes mellitus associated with glycogen storage disease type III. Muscle Nerve 39:876–877CrossRefGoogle Scholar
  29. Spiegel R, Rakover-Tenenbaum Y, Mandel H, Lumelski D, Admoni O, Horovitz Y (2005) Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. J Pediatr Endocrinol Metab 18:617–619CrossRefGoogle Scholar
  30. American Diabetes Association (2018) Standards of medical care in diabetes—2018; abridged for primary care providers. Clin Diabetes 36:14–37CrossRefGoogle Scholar
  31. White FJ, Jones SA (2011) The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 34:631–642CrossRefGoogle Scholar
  32. Yoo HJ, An HG, Park SY, Ryu OH, Kim HY, Seo JA, Hong EG, Shin DH, Kim YH, Kim SG, Choi KM, Park IB, Yu JM, Baik SH (2008) Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 82:73–79CrossRefGoogle Scholar

Copyright information

© SSIEM 2018

Authors and Affiliations

  • Mrudu Herbert
    • 1
  • Surekha Pendyal
    • 1
  • Mugdha Rairikar
    • 1
  • Carine Halaby
    • 1
  • Robert W. Benjamin
    • 2
  • Priya S. Kishnani
    • 1
    Email author
  1. 1.Division of Medical Genetics, Department of PediatricsDuke University Medical CenterDurhamUSA
  2. 2.Division of Endocrinology, Department of PediatricsDuke University School of MedicineDurhamUSA

Personalised recommendations